
    
      Eligible subjects will be randomized in a 1:1 ratio to receive either ProF-001 or fluconazole
      for the treatment of RVVC.

      Patients diagnosed with RVVC will be randomized to either ProF-001 or fluconazole treatment.
      Treatment schedule will start with an induction period of 10 (+4) days followed by a six
      months maintenance period and a subsequent 6 months follow-up (observation) period after end
      of active treatment.

      Any episode of VVC grade > = 3 and positive vaginal smear (native or KOH) with budding
      yeasts, pseudohyphae or hyphae from test of cure (TOC) visit onwards will be considered as
      relapse of VVC.
    
  